2020
DOI: 10.1016/j.biomaterials.2019.119545
|View full text |Cite
|
Sign up to set email alerts
|

Radiosensitive core/satellite ternary heteronanostructure for multimodal imaging-guided synergistic cancer radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 61 publications
(38 citation statements)
references
References 73 publications
1
37
0
Order By: Relevance
“…In order to enhance the efficiency of radiotherapy, materials containing a high atomic number (high-Z) element were usually considered as RSs since they can release a large amount of energy in their immediate vicinity through the Auger effect and photoelectric effect when receiving radiation. [4][5][6] The released large amount of energy was proposed to cause overproduction of reactive oxygen species (ROS) to break the DNA strand and nally induce cell death. 7 Until now, platinum analogues especially cisplatin are the most commonly used agents as RSs and have been proved to target DNA.…”
Section: Introductionmentioning
confidence: 99%
“…In order to enhance the efficiency of radiotherapy, materials containing a high atomic number (high-Z) element were usually considered as RSs since they can release a large amount of energy in their immediate vicinity through the Auger effect and photoelectric effect when receiving radiation. [4][5][6] The released large amount of energy was proposed to cause overproduction of reactive oxygen species (ROS) to break the DNA strand and nally induce cell death. 7 Until now, platinum analogues especially cisplatin are the most commonly used agents as RSs and have been proved to target DNA.…”
Section: Introductionmentioning
confidence: 99%
“…This part of experimental methods refer to the previous published articles [ [51] , [52] , [53] ].1 μmol EDC and 1 μmol NHS were added to the solution of ICG-COOH (10 mM, 200 μL) to activate the eCOOH, and the mixture was thoroughly incorporated. MIL101-NH 2 (10 mg/mL, 1 mL) was then added.…”
Section: Methodsmentioning
confidence: 99%
“…Advances in nanotechnology have facilitated the development of delivery systems to treat prostate-related disorders. Advantages of nanocarrier preparations include the combination of a variety of drugs, including biomacromolecule drugs; reduced degradation of unstable drugs for slow and controlled release; and increased residence time of relevant drugs to avoid frequent injections and meet the needs of prostatitis treatment ( Thakur and Agrawal, 2015 ; Liu et al, 2020 ; Liu et al, 2020 ; Wang et al, 2020 ; Lin et al, 2021 ; Liu et al, 2021 ). More importantly, the modular design and preparation characteristics of nanotechnology endow nanomaterials with intelligent characteristics ( van der Meel et al, 2019 ).…”
Section: Application Of Functionalized Nanomaterials In Prostatitismentioning
confidence: 99%